Results 211 to 220 of about 1,846,055 (403)
The Laryngoscope, EarlyView.Prospective study from April 2021 to August 2024 of adult patients with refractory chronic cough undergoing SLN block. This prospective assessment indicates that nearly 2 in 3 refractory chronic cough patients respond positively at 2 weeks post injection, with around 50% of these initial improvers endorsing ongoing cough symptom improvement at 6–9 ...
Andrew T. Peachman +5 more
wiley +1 more source
Central and peripheral sites of action for CB2 receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats [PDF]
, 2010 Gin C. Hsieh +12 more
openalex +1 more source
Mass Spectrometry Reviews, EarlyView.ABSTRACT Phytocannabinoids are bioactive metabolites derived from the Cannabis sativa plant. They have garnered attention due to their recreational uses and therapeutic potential. Although various analytical strategies have been employed for their analysis, mass spectrometry (MS) coupled to chromatographic separation is superior due to its sensitivity ...
Radwa Mahmoud +2 more
wiley +1 more source
Distinction and mutual Influences between Parkinson's Disease‐related and unrelated Chronic Pain
Movement Disorders Clinical Practice, EarlyView.Abstract Background Chronic pain (i.e. > 3 months) is a common nonmotor symptom in patients with Parkinson's disease (PD), but the attribution to PD is critical for further treatment. Objectives We explored the PD Pain Classification System (PD‐PCS) criteria for the diagnosis of PD‐related pain and mutual influences between PD‐related and PD‐unrelated ...
Jonathan Hunger +11 more
wiley +1 more source
Therapeutic Effects of GLP-1 Receptor Agonists and DPP-4 Inhibitors in Neuropathic Pain: Mechanisms and Clinical Implications [PDF]
Yaswanth Kuthati +2 more
openalex +1 more source
Managing Dystonia in Partington Syndrome
Movement Disorders Clinical Practice, EarlyView.Abstract Background Bilateral focal hand dystonia is an almost pathognomonic sign of Partington syndrome, frequently accompanied by intellectual disability and oromotor dyspraxia. However, a few studies have focused on the treatment of this focal dystonia, making patient management uncertain.
Emilie Pichon +13 more
wiley +1 more source
Transdermal Lidocaine and Ketamine for Neuropathic Pain: A Study of Effectiveness and Tolerability [PDF]
, 2012 Emily Tam
openalex +1 more source
Movement Disorders Clinical Practice, EarlyView.Abstract Background Axial postural abnormalities (APAs) are common, disabling complications of Parkinson's disease (PD) with unclear pathophysiology. The presence of hyperactivity in multiple trunk muscles supports the use of botulinum toxin (BTA). However, its application is complex, due to the lack of standardized clinical and electrophysiological ...
Giacomo Argenziano +7 more
wiley +1 more source
Movement Disorders, EarlyView.The “second‐hit” hypothesis proposes that both a genetic predisposition and an environmental insult—such as peripheral nerve trauma or spinal cord injury—are required for dystonia development. This review explores how neuroinflammation and maladaptive plasticity, triggered by nerve and spinal cord injury, contribute to dystonia pathogenesis.
Lisa Harder‐Rauschenberger +1 more
wiley +1 more source
Patients′ Attitudes and Prior Treatments in Neuropathic Pain: A Pilot Study [PDF]
, 2002 Ian Gilron +3 more
openalex +1 more source